PMV Pharmaceuticals (PMVP)
(Delayed Data from NSDQ)
$1.55 USD
+0.02 (1.31%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.55 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
PMV Pharmaceuticals, Inc. [PMVP]
Reports for Purchase
Showing records 1 - 17 ( 17 total )
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Rezatapopt Companion Diagnostic Deal With Foundation Medicine; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Updated Phase 1/2 PYNNACLE Results Presented; Lowering PT to $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
PYNNACLE Trial Data by Year-End; 2Q23 Financials; Modulating PT to $29
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
PYNNACLE Trial Results Expected by Year-End; 1Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Updated PC14586 Results in 2H23; 2022 Financials; Modulating PT to $35
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
PC14586 Demonstrates Highly Encouraging Response Rate in Dose Escalation
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Initial PC14586 Results Slated for ASCO; 1Q22 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Initial Phase 1 Data Expected in 1H22; 2021 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Initial PC14586 Results Slated for 1H22; 3Q21 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: PMV Pharmaceuticals, Inc.
Industry: Medical - Drugs
Reawakening the Guardian of the Genome; Initiating at Buy and $63 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
|